Effects of pharmacist interventions on reducing prescribing errors of investigational drugs in oncology clinical trialsJOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, v.26 no.1, 29-35
Factors affecting high-grade hepatotoxicity of tyrosine kinase inhibitors in cancer patients: a multi-center observational studyEuropean Journal of Clinical Pharmacology, 2020, v.76 no.8, 1183-1191
Risk factors associated with the incidence and time to onset of lapatinib-induced hepatotoxicityBreast Cancer Research and Treatment, 2019, v.178 no.1, 239-244